Nearly 90% of U.S. gastroenterologists are open to using AI for help performing high quality colonoscopies. And of these, 85% believe that computer-assisted polyp detection (CADe) stands to improve their endoscopic performance.
Along with new or improved algorithmic applications for chest imaging, watch for word of an AI-powered breathalyzer and other diagnostic techno-weapons aimed at COVID. What they’ll all have in common is full-throated NIH support.
The FDA has OK’d the sixth medical AI application developed by Israel-based Zebra Medical Vision. The latest iteration helps breast-specialized radiologists by flagging questionable lesions appearing in 2D mammograms.